Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma;Resultados del protocolo SHOP LNHB98 (LMB89) en pacientes de edad pediátrica afectados de linfoma no hodgkiniano de células B

Medicina Clinica

Volumn 128, Issue 17, 2007, Pages 641-646

  Forns, Marga ^a   Javier, Germán ^a   Estella, Jesús ^b   Fernández Delgado, Rafael ^c   Gallego, Soledad ^d   García Miguel, Purificación ^e   Indiano, José M ^f   Navajas, Aurora ^g   Pardo, Nuria ^h  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL DE BASURTO   (Spain)

^g HOSPITAL DE CRUCES   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

B cell lymphoma; Diffuse lymphoma; High grade lymphoma; Large cell lymphoma; Pediatrics

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; MELPHALAN;

ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; TREATMENT OUTCOME;

EID: 34347207935     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13102049     Document Type: Article

References (27)

1. Patte C, Aupenin A, Michon J, Behrendt H, Leverger G, Frappaz D, et al. The Société d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemoterapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97:3370-9.
2. Patte C, Philip T, Rodary C, Bernard A, Zucker JM, Bernard JL, et al. Improved survival rate in children with stage III and IV cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol. 1986;4:1219-26.
3. Patte C, Philip T, Rodary C, Zucker JM, Behrendt H, Gentet JC, et al. High survival rate in advanced-stage-B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemoterapy: results from the French Pediatric Oncology Society of a randomized trial of a 216 children. J Clin Oncol. 1991; 9:123-32.
4. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332-9.
5. Rubino C, Laplanche A, Patte C, Michon J. Cost-minimization analysis of prophylactic colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma. J Natl Cancer Inst. 1998;90:750-5.
6. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
7. Rothman KJ. Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis. 1978;31:557-60.
8. Peto R, Pike MC, Armitage P, Bresiow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer. 1977;35:1-39.
9. Ajaenkin RD, Anderson JR, Chilcote RR, Coccia PF, Exelby PR, Kersey JM, et al. The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group. J Clin Oncol. 1984;2:88-97.
10. Meadows AT, Sposto R, Jenkin RD, Kersey JH, Chilcote RR, Slegel SE, et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Children Cancer Study Group. J Clin Oncol. 1989;7:92-9.
11. Murphy SB, Hustu HO. A randomized trial of combined modality therapy of chilhoodnon-Hodgkin's lymphoma. Cancer. 1980;45:630-7.
12. Patte C, Rodary C, Sarrazin D, Bernard A, Lemerle J. Results of treatment of 178 pediatric non Hodgkin's malignant lymphomas between 1973 and 1978. Arch Fr Pediatr. 1981;38:321-7.
13. Patte C, Lemente J. Malignant B-cell lymphoma. En: Barnett MJ, Blood HJG, Lemente J, editors. Cancer in children, clinical management (UICC handbook). Berlin: Springer; 1992. p. 128-40.
14. Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005;105: 948-58.
15. Link MP, Donaldson SS, Berard CW, Shuster JJ, Murphy SB. Results of treatment of childhood localizad non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med. 1990;322:1169-74.
16. Link MP, Shuster JJ, Donaldson SS, Bernard CW, Murphy SB. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med. 1997;337:1259-66.
17. Haddy TB, Adde MA, Magrath IT. CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se poor prognostic sign? J Clin Oncol. 1991;9:1973-82.
18. Bergeron C, Patte C, Caillaud JM, Bernard A, Bayle C, Lubdinski B, et al. Clinical, anatomopathologic aspects and therapeutic results in 63 malignant ORL non-Hodgkin's lymphomas in children. Arch Fr Pediatr. 1989;46:583-7.
19. Magrath I, Adde M, Shad A, Venzod D, Seibel N, Gootenberg J, et al. Adults and children with small non-cleaved-cell-lymphma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14: 925-34.
20. Todeschini G, Tecchio C, Degani D, Meneghini V, Marradi P, Balter R, et al. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol. Ann Oncol. 1997;8 Suppl 1:77-81.
21. Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Fullen J, et al. Improved survival for children with B-cell acute lymphoblastic leucemia and stage IV small noncleaved-cell lymphoma: a pediatric, oncology group study. J Clin Oncol. 1996; 14:1252-61.
22. Mann G, Yakisan E, Schrappe M. Diffuse large B-cell lymphomas in childhood and adolescente: favorable outcome with a Burkitt's lymphoma directed therapy in trial NHL-BFM 90. Areport of the BFM group. Med Pediatr Oncol. 1997; 29:358.
23. Hutchison RE, Berard CW, Shuster JJ, Link MP, Pick TE, Murphy SB, et al. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study. J Clin Oncol. 1995;13: 2023-32.
24. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yasikan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasm with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood. 1999;94:3294-306.
25. Patte C, Sakiroglu C, Aneoborlo S, Baruchel A, Plouvier E, Pacquomen H, et al. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Française d'Oncologie Pediatrique LMB89 protocol. Ann Oncol. 2002;13:789-95.
26. Pui CH, Relling MV, Lascombes F, Harison PL, Struxiano A, Mondesir JM, et al. Urate oxidase in prevention and treatment of hyperuricaemia associated with lymphoid malignancies. Leukemia. 1997;11:1813-6.
27. Mahmoud HH, Leverger G, Patte C, Harvey E, Lescombes F. Advances in the management of malignancy-associated hyperuricaemia. Br J Cancer. 1998;77 Suppl 4:18-20.